chart and annual meeting

Here is BigCharts presentation of NAL:

http://bigcharts.marketwatch.com/javachart/javachart.asp?symb=AU%3ANAL&time=&freq=

As mentioned, the buying is continuing to be strong thereby avoiding a retracement.

Instead it is trading sideways in a narrow range: $2.09-$2.14 since 3 Nov.

Let us hope it manages to do that for another week or so and then start another slow rise till we get some news.

Waiting for that proposed agreement with a major Pharma. This to be followed by 2 listings: the immunology division to be listed in Londen and NAL to be listed at the Nasdaq (ADR).

And what wil be NAL's price in MAY?
I won't answer that but the listings ought to replace cheap Aussie prices by upmarket UK and US prices.

I am rating it NAL #3 after NRT and CMQ.

Meeting is on 27 Nov. A lot can happen before that!

Gerry
Please do your own research and you decide if and when to buy, hold or sell any stocks.